Home > Insider Trading > Filing (0001395064-21-000105)

Filing Details

Accession Number:: 0001395064-21-000105
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-06-02 06:08:12
Reporting Period:: 2021-05-28

Accepted Time:: 2021-06-02 06:08:12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1783183	Phathom Pharmaceuticals Inc.	PHAT	Pharmaceutical Preparations (2834)	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1395064	Takeda Pharmaceutical Co Ltd	1-1, Nihonbashi-Honcho 2-Chome Chuo-Ku, Tokyo M0 103-8668		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2021-05-28	4,133	$35.37	964,652	No	4	S	Direct
Common Stock	Disposition	2021-05-28	2,668	$36.40	961,984	No	4	S	Direct
Common Stock	Disposition	2021-05-28	2,104	$37.55	959,880	No	4	S	Direct
Common Stock	Disposition	2021-06-01	7,244	$35.55	952,636	No	4	S	Direct
Common Stock	Disposition	2021-06-01	3,967	$36.20	948,669	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 2, 2021.
Reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $35.00 to $35.99. Information regarding the number of shares sold at each separate price will be provided upon request by the Staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer.
Reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $36.00 to $36.96. Information regarding the number of shares sold at each separate price will be provided upon request by the Staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer.
Reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $37.00 to $37.99. Information regarding the number of shares sold at each separate price will be provided upon request by the Staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer.
Reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $35.01 to $35.99. Information regarding the number of shares sold at each separate price will be provided upon request by the Staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer.
Reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $36.00 to $36.55. Information regarding the number of shares sold at each separate price will be provided upon request by the Staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer.